Is Global Health Security Worth 0.01% of Our Gross Domestic Product?

7 Pages Posted: 13 Mar 2025

See all articles by Gorik Ooms

Gorik Ooms

Institute of Tropical Medicine; Ghent University

Yibeltal Assefa

University of Queensland - School of Public Health

Ter Tiero Elias Dah

Université de Ouahigouya

Kristof Decoster

Institute of Tropical Medicine

Bouke C. de Jong

Institute of Tropical Medicine - Mycobacteriology Unit

Bernadette Hensen

Institute of Tropical Medicine

Ryuichi Komatsu

University of Nagasaki

Natama Hamtandi Magloire

Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro

Ellen M.H. Mitchell

Institute of Tropical Medicine

Thijs Reyniers

University of Tübingen - Institute of Tropical Medicine

Anna Rosanas-Urgell

Institute of Tropical Medicine

Maria-Belen Tarrafeta-Sayas

Institute of Tropical Medicine

Halidou Tinto

Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro

Alan Whiteside

affiliation not provided to SSRN

Raffaella Ravinetto

Institute of Tropical Medicine; University of the Western Cape - School of Public Health

Date Written: March 11, 2025

Abstract

The global health responses to HIV, tuberculosis (TB), and malaria have long been supported by the United States (US) through significant financial commitments, particularly via initiatives like the President’s Emergency Plan for AIDS Relief (PEPFAR) and USAID. However, within days of Donald Trump’s second presidential term, the US abruptly ceased most of its contributions to global health programs, severely impacting efforts to control these diseases. This decision violates the right to health, undermining the global health security framework and the collective international responses. HIV, TB, and malaria are not isolated issues; their control is critical to global health security, as these diseases continue to cause millions of deaths worldwide. The cessation of US funding is projected to result in an additional 6 million deaths and 9 million new HIV infections by 2029 alone. TB and malaria also face heightened risks due to drug resistance, insufficient healthcare access, and climate change. The withdrawal of US support for these programs further exacerbates the crisis, particularly in resource-poor regions, where local governments lack the capacity to replace this lost funding. As the Global Fund to Fight AIDS, TB, and Malaria enters its replenishment cycle, securing the necessary funding becomes increasingly urgent to prevent devastating setbacks in global health progress. The article calls for immediate international action to protect and replenish the Global Fund, emphasizing the need for equitable financial contributions from all countries, including low- and middle-income nations. Furthermore, the governance of global health initiatives must be reformed to ensure fair decision-making power and sustained long-term funding for global health security. The article argues that these actions are not only morally imperative but also strategically essential to maintain global health stability and prevent future health crises.

Keywords: global health security, global health governance

Suggested Citation

Ooms, Gorik and Assefa, Yibeltal and Dah, Ter Tiero Elias and Decoster, Kristof and de Jong, Bouke C. and Hensen, Bernadette and Komatsu, Ryuichi and Magloire, Natama Hamtandi and Mitchell, Ellen M.H. and Reyniers, Thijs and Rosanas-Urgell, Anna and Tarrafeta-Sayas, Maria-Belen and Tinto, Halidou and Whiteside, Alan and Ravinetto, Raffaella, Is Global Health Security Worth 0.01% of Our Gross Domestic Product? (March 11, 2025). Available at SSRN: https://ssrn.com/abstract=5176303 or http://dx.doi.org/10.2139/ssrn.5176303

Gorik Ooms (Contact Author)

Institute of Tropical Medicine ( email )

Nationalestraat 155
Antwerp, 2000
Belgium

Ghent University ( email )

Ghent, 9000
Belgium

Yibeltal Assefa

University of Queensland - School of Public Health ( email )

St Lucia
Brisbane
Australia

Ter Tiero Elias Dah

Université de Ouahigouya ( email )

Kristof Decoster

Institute of Tropical Medicine ( email )

Bouke C. De Jong

Institute of Tropical Medicine - Mycobacteriology Unit ( email )

B-2000 Antwerp
Belgium

Bernadette Hensen

Institute of Tropical Medicine ( email )

Antwerp
Belgium

Ryuichi Komatsu

University of Nagasaki ( email )

Natama Hamtandi Magloire

Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro ( email )

Ellen M.H. Mitchell

Institute of Tropical Medicine ( email )

Antwerp
Belgium

Thijs Reyniers

University of Tübingen - Institute of Tropical Medicine ( email )

Tübingen
Germany

Anna Rosanas-Urgell

Institute of Tropical Medicine ( email )

Maria-Belen Tarrafeta-Sayas

Institute of Tropical Medicine ( email )

Halidou Tinto

Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro ( email )

Burkina Faso

Alan Whiteside

affiliation not provided to SSRN

Raffaella Ravinetto

Institute of Tropical Medicine ( email )

Nationalestraat 155
Antwerp, 2000
Belgium

University of the Western Cape - School of Public Health ( email )

Cape Town
South Africa

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
130
Abstract Views
349
Rank
479,450
PlumX Metrics